SIG-1451: A Topical Anti-Inflammatory New Chemical Entity for Atopic Dermatitis

    José R. Fernández, Karl Rouzard, Corey Webb, Michael V. Voronkov, Jason Healy, Kristen L. Huber, Jeffry B. Stock, Maxwell Stock, Joel S. Gordon, Eduardo Salcedo Pérez
    Image
    Studysummary In laboratory tests and mouse models, this study found that the novel IPC analog SIG-1451 may offer potent anti-inflammatory effects for treating allergic skin inflammation, potentially outperforming some current therapies in specific inflammatory phases.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →